Company intelligence / Profile preview

Duplex Bioscience

Ownership: Private
Development stage: Preclinical

Overview

Duplex Bioscience is a Ghanaian biotech startup focused on developing affordable molecular detection platforms and diagnostic kits for both communicable and non-communicable diseases. Their approach leverages next-generation sequencing methods to build Africa’s largest multiomics database for biomarker discovery. They have developed microBIS.io—a proprietary AI-driven platform—to improve bacterial identification and antimicrobial resistance diagnosis. The company emphasizes local manufacturing of enzymes for multiplex diagnosis of conditions like candidiasis and STIs[5].

Therapeutic areas: CardiovascularInfectious Diseases
Modalities: Molecular diagnostics platformsbiosensor kitsmultiomics data analysis
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Duplex Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Duplex Bioscience.

Explore the full profile